TLR2 and neoplasm: Furthermore, different interventions were administered to the tumor metastasis model (Fig. 7b), including inhibiting HMGB1 secretion from the cytoplasm, inhibiting the function of the HMG box of HMGB1, inhibiting the activation of TLR2, or clearance of the formed NETs.